Showing results (141-150 of 458) with videos related to
Sort By:
Pageof 46
Cardiovascular Drugs and Therapy|March 7, 2007
Genetic variation in the B-type natiuretic peptide pathway affects BNP levelsDavid E Lanfear, Joshua M Stolker, Sharon Marsh, et al.Molecular Cancer Therapeutics|October 6, 2011
Genomic profiling in CEPH cell lines distinguishes between the camptothecins and indenoisoquinolinesVenita Gresham Watson, Nicholas E Hardison, Tyndall Harris, et al.The Lancet. Oncology|November 3, 2009
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009Ross A Soo, Benjamin O Anderson, Byoung Chul Cho, et al.Chinese Clinical Oncology|April 29, 2016
Advances in systemic treatment for nasopharyngeal carcinomaWan-Ling Tan, Eng-Huat Tan, Darren Wan-Teck Lim, et al.Pharmacogenomics|June 23, 2011
Pharmacogenetics and rational drug use around the worldMary W Roederer, Francisco Sanchez-Giron, Kusha Kalideen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trialHanna K Sanoff, Daniel J Sargent, Erin M Green, et al.Oncology Reports|February 12, 2002
Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasisSharon Marsh, Judith A McKay, Stephanie Curran, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2015
Single-Nucleotide Polymorphisms in Cytochrome P450 2E1 (CYP2E1) 3'-Untranslated Region Affect the Regulation of CYP2E1 by miR-570Masataka Nakano, Takuya Mohri, Tatsuki Fukami, et al.Human Pathology|November 28, 2002
Topoisomerase I protein expression in primary colorectal cancer and lymph node metastasesAttasit Boonsong, Stephanie Curran, Judith A McKay, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 19, 2005
Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activityTatsuki Fukami, Miki Nakajima, Eriko Higashi, et al.Pageof 46